Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature
Volume: 48, Issue: 01, Pages: 055 - 071
Published: Jun 15, 2021
Abstract
The term "lupus anticoagulant (LA)" identifies a form of antiphospholipid antibodies (aPLs) causing prolongation of clotting tests in a phospholipid concentration-dependent manner. LA is one of the laboratory criteria identified in patients with antiphospholipid (antibody) syndrome (APS). The presence of LA in patients with APS represents a significant risk factor for both thrombosis and pregnancy morbidity. There have been several reports of...
Paper Details
Title
Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature
Published Date
Jun 15, 2021
Volume
48
Issue
01
Pages
055 - 071
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History